CBIO vs OMC · rev $1.0M vs rev $17.27B
Crescent Biopharma, Inc. (CBIO) versus Omnicom Group Inc (OMC) — a side-by-side from cached financials, not a winner call.
Crescent Biopharma, Inc. (CBIO) is a biotechnology company listed on NASDAQ.
Omnicom Group Inc (OMC) is a advertising agencies company listed on NYSE.
Latest reported CBIO revenue for 2026-06-30 was $1.0M. Net income was -$48.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. CBIO currently screens at market cap $491.3M.
Latest reported OMC revenue for 2025-12-31 was $17.27B. Net income was -$54.5M. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. OMC currently screens at market cap $21.75B.
CBIO currently screens at market cap $491.3M. OMC currently screens at market cap $21.75B.
Not investment advice. Open the CBIO and OMC stock pages for the full models.
Not investment advice.